CRISPR, Gene Editing & DNA-Repair Antibodies
CRISPR efficiency is only part of the result. Evaluate DNA-damage signaling, repair-pathway activation, and editing outcomes with antibodies targeting Cas9, RAD51, BRCA2, DNA-PK, γH2AX, ATM, ATR, and other key genome-stability proteins.
Catalog #1: bsm-52481R
Applications: WB, FCM, IHC-P, IF(ICC), IHC
Reactivity: Human, Mouse
Conjugate: Unconjugated
Catalog #1: bs-70354r
Applications: WB, IHC
Reactivity: Human, Mouse, Rat
Conjugate: Unconjugated
Catalog #1: bsm-52360r
Applications: WB, IHC-P, IHC-F, IF, ICC/IF
Reactivity: Human
Conjugate: Unconjugated
Catalog #1: bsm-54575R
Applications: WB, IHC-P, IHC
Reactivity: Human
Conjugate: Unconjugated
Catalog #1: bsm-52522R
Applications: WB, IHC-P, IF(ICC), IHC
Reactivity: Human
Conjugate: Unconjugated
Catalog #1: bsm-52974r
Applications: WB, IHC-P, IHC-F, IF
Reactivity: Human, Mouse, Rat
Conjugate: Unconjugated
Catalog #1: bsm-52512r-TR
Applications: WB, IHC-P, IHC-F, IF(IHC-P), IF(ICC)
Reactivity: Human
Conjugate: Unconjugated
Catalog #1: bsm-70054M
Applications: WB, IHC
Reactivity: Others
Conjugate: Unconjugated